Form 4: Surgery Partners' Chief Strategy Officer Sells Shares to Cover Tax Obligations

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 14,700 shares of common stock on February 7, 2025, to cover tax obligations related to the vesting of restricted stock.

Summary

• On February 7, 2025, Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc., sold 14,700 shares of the company's common stock.
• The sale was executed at a weighted average price of $25.61 per share.
• This transaction was conducted to satisfy tax withholding obligations associated with the vesting of restricted stock on January 31, 2025, and February 1, 2025.
• Following the reported transaction, Brittenham directly owns 50,178 shares of Surgery Partners, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes, which is a neutral event.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives. It's common for executives to sell shares to cover tax obligations related to stock vesting.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.

Key Dates